6 semaglutide PIONEER 6: Oral Passes Test in Cardiovascular Outcomes Study D-[Phe]-6-Semaglutide - Veeprho

Wegovy (semaglutide) injection, for subcutaneous use Prescribing Information

We also share tips for minimising injection site reactions with Wegovy

Marasco, G

The gut-brain axis has emerged as a compelling frontier in neuroprotection, characterized by complex bidirectional communication between the CNS, the enteric nervous system, and the intestinal microbiota

Injection site reactions in a smaller subset of patients: Mild redness, localised swelling, or skin sensitivity at the injection site shows up in some patients and typically resolves without needing any intervention as the body settles into regular administration